OA-484 Improving rapid detection of 2nd line drug resistance in Mycobacterium tuberculosis with Xpert MTB/XDR and MolBio 2nd line
Massou, Faridath, Ba, Awa, Bah, Kindy Sadio, Vuchas, Comfort, Muse, Fadeyi, Kaswa, Michel Kayomo, Semuto, Claude, Abebe, Gemeda, Diarra, Bassirou, Jong, Bouke de, Supply, Philip, Flyod, Sian, Merle, Corinne, Affolabi, Dissou
Published in BMJ global health (17.12.2023)
Published in BMJ global health (17.12.2023)
Get full text
Journal Article
Four-Month High-Dose Rifampicin Regimens for Pulmonary Tuberculosis
Jindani, Amina, Atwine, Daniel, Grint, Daniel, Bah, Boubacar, Adams, Jack, Ticona, Eduardo Rómulo, Shrestha, Bhabana, Agizew, Tefera, Hamid, Saeed, Jamil, Bushra, Byamukama, Adolf, Kananura, Keneth, Mugisha Taremwa, Ivan, Bonnet, Maryline, Camara, Lansana Mady, Bah-Sow, Oumou Younoussa, Bah, Kindy Sadio, Bah, Nene Mamata, Sow, Maimouna, Ticona Huaroto, César Eduardo, Mugruza Pineda, Raquel, Tandukar, Bijesh, Raya, Bijendra Bhakta, Shrestha, Neko, Mathoma, Anikie, Mathebula-Modongo, Unami P, Basotli, Joyce, Irfan, Muhammad, Begum, Dilshad, Muzammil, Ammara, Ahmed, Imran, Hasan, Rumina, Burgos, Marcos V, Sultan, Faisal, Hassan, Mariam, Masood, Iqra, Robb, Claire, Decker, Jonathan, Grubnic, Sisa, Butcher, Philip D, Witney, Adam, Dhillon, Jasvir, Munshi, Tulika, Fielding, Katherine, Harrison, Thomas S
Published in NEJM evidence (01.09.2023)
Published in NEJM evidence (01.09.2023)
Get more information
Journal Article